Process for preparing pharmaceutically active compounds and intermediates thereof
A process is disclosed for the preparation of (1) by reduction of (2) directly using catalytic transfer hydrogenation to suppress formation of (4) or by conventional reduction via (4). Compound (1) is a key intermediate for inter alia paroxetine.
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | A process is disclosed for the preparation of (1) by reduction of (2) directly using catalytic transfer hydrogenation to suppress formation of (4) or by conventional reduction via (4). Compound (1) is a key intermediate for inter alia paroxetine. |
|---|